Scavenger receptor (immunology)

Scavenger receptor
Identifiers
Symbol Scavenger receptor
OPM superfamily 456
OPM protein 5ktf
Membranome 4

Scavenger receptors are receptors on macrophages and other cells that bind to numerous ligands, such as bacterial cell-wall components, and remove them from the blood. The Kupffer cells in the liver are particularly rich in scavenger receptors. Includes SR-A I, SR-A II, and MARCO.[1]

Function

Scavenger receptors are thought to participate in the removal of many foreign substances and waste materials in the living body by extensive ligand specificity and a variety of receptor molecules.

In atherosclerotic lesions, macrophages that express scavenger receptors on their plasma membrane take up the oxidized LDL deposited in the blood vessel wall aggressively, and develop into foam cells. Likewise, they secrete various inflammatory cytokines and accelerate the development of atherosclerosis.

Types

Scavenger receptors are categorized into classes A, B, C according to their structural characteristics.

Class A

Scavenger receptors type 1 (SR-A1) and 2 (SR-A2) are trimers with a molecular weight of about 220-250 kDa (the molecular weight of monomeric protein is about 80 kDa). They preferentially bind modified LDL, either acylated (acLDL) or oxidized (oxLDL). They have a collagen-like domain, which is essential for ligand binding.

Members include:

  • SCARA1 or MSR1: SR-A1 scavenger receptors have a cysteine-rich domain, which can be found in a series of cell surface receptors and soluble proteins, but SR-A2 do not.
  • SCARA2 or MARCO: Another scavenger receptor class A, MARCO, has collagen-like and cysteine-rich domains.
  • SCARA3
  • SCARA4 or COLEC12
  • SCARA5
  • MARCO : macrophage receptor with collagenous structure

Class B

CD36 and scavenger receptor class BI (SR-BI) are identified as oxidized LDL receptors and classified into class B. Both proteins have two transmembrane domains, and they are concentrated in a specific plasma membrane microdomain, the caveolae.

Members include:

  • SCARB1. SR-BI can interact not only with oxidized LDL but also with normal LDL and high-density lipoproteins (HDL). Recent studies have indicated that SR-BI is likely to be the major receptor involved in HDL metabolism in mice and humans.[3][4]
  • SCARB2
  • SCARB3 or CD36. CD36 has been thought to be implicated in cell adhesion, in the phagocytosis of apoptotic cells, and in the metabolism of long-chain fatty acids. In experimental mice models of atherosclerosis in which the gene for CD36 has been deleted, the mice have a greatly reduced number of atherosclerotic lesions.[5]

Other

Some receptors that can bind to oxidized LDL have been discovered.

References

  1. Murphy K, Weaver C. Janeway's immunobiology (Ninth ed.). New York, NY, USA. ISBN 978-0-8153-4505-3. OCLC 933586700.
  2. Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, Kanamori H, Aburatani H, Takaku F, Suzuki H (December 1990). "Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions". Proceedings of the National Academy of Sciences of the United States of America. 87 (23): 9133–7. doi:10.1073/pnas.87.23.9133. PMC 55118. PMID 2251254.
  3. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M (November 1997). "A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism". Proceedings of the National Academy of Sciences of the United States of America. 94 (23): 12610–5. doi:10.1073/pnas.94.23.12610. PMC 25055. PMID 9356497.
  4. Khovidhunkit W (April 2011). "A genetic variant of the scavenger receptor BI in humans". The New England Journal of Medicine. 364 (14): 1375–6, author reply 1376. doi:10.1056/NEJMc1101847#SA1. PMID 21470028.
  5. Kuchibhotla S, Vanegas D, Kennedy DJ, Guy E, Nimako G, Morton RE, Febbraio M (April 2008). "Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II". Cardiovascular Research. 78 (1): 185–96. doi:10.1093/cvr/cvm093. PMC 2810680. PMID 18065445.
  6. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G (January 2006). "Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders". Cardiovascular Research. 69 (1): 36–45. doi:10.1016/j.cardiores.2005.09.006. PMID 16324688.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.